Range Low Price High Price Comment
30 days $58.40 $79.59 Monday, 29th Apr 2024 EXAS stock ended at $58.78. This is 0.119% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 2.92% from a day low at $58.62 to a day high of $60.33.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Feb 01, 2016 $6.55 $6.63 $6.37 $6.48 1 492 500
Jan 29, 2016 $6.27 $6.66 $6.23 $6.57 2 476 700
Jan 28, 2016 $6.64 $6.73 $6.17 $6.23 1 761 800
Jan 27, 2016 $6.67 $6.86 $6.47 $6.60 1 638 200
Jan 26, 2016 $6.42 $6.79 $6.21 $6.67 1 475 800
Jan 25, 2016 $6.34 $6.68 $6.27 $6.30 1 638 900
Jan 22, 2016 $6.45 $6.59 $6.25 $6.37 1 596 400
Jan 21, 2016 $6.28 $6.85 $6.22 $6.36 2 166 000
Jan 20, 2016 $6.08 $6.33 $5.77 $6.26 3 262 200
Jan 19, 2016 $6.70 $6.74 $6.05 $6.26 1 967 100
Jan 15, 2016 $6.76 $6.89 $6.26 $6.62 1 808 700
Jan 14, 2016 $6.96 $7.19 $6.63 $6.99 2 651 600
Jan 13, 2016 $7.36 $7.53 $6.65 $6.70 3 267 600
Jan 12, 2016 $7.10 $7.35 $6.81 $7.34 2 576 700
Jan 11, 2016 $7.75 $7.78 $6.85 $6.99 3 296 300
Jan 08, 2016 $8.23 $8.48 $7.74 $7.98 2 466 000
Jan 07, 2016 $7.95 $8.50 $7.81 $8.15 2 064 700
Jan 06, 2016 $8.33 $8.49 $7.77 $8.12 3 095 500
Jan 05, 2016 $9.05 $9.22 $8.44 $8.50 2 449 900
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT